Immunotherapy with allergen peptides.

about

Orchestrating house dust mite-associated allergy in the lung.Can we vaccinate against Type 1 diabetes?Pepsinized cashew proteins are hypoallergenic and immunogenic and provide effective immunotherapy in mice with cashew allergy.Advances in synthetic peptide immuno-regulatory epitopes.

P2860

Q36054545-059BD771-0835-4B44-A58B-8DC42370088B Q36296386-DAD085F3-AFDD-4D23-8BED-DD1EB0A18BFE Q37260142-DB62A7D6-A8AD-4479-86BB-81BF9DDA1467 Q38268100-09F91C04-E476-4599-A1D6-8D72A347D7A4

P2860

Immunotherapy with allergen peptides.

Item

http://www.wikidata.org/entity/Q40657944

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Immunotherapy with allergen peptides.

@en

type

Item

label

Immunotherapy with allergen peptides.

@en

prefLabel

Immunotherapy with allergen peptides.

@en

P1476

Immunotherapy with allergen peptides.

@en

P2093

Mark Larché

http://www.w3.org/2001/XMLSchema#string

P2860

T cell epitope immunotherapy induces a CD4+ T cell population with regulatory activity

Greater risk of incident asthma cases in adults with allergic rhinitis and effect of allergen immunotherapy: a retrospective cohort study.

Peripheral T-cell tolerance induced in naive and primed mice by subcutaneous injection of peptides from the major cat allergen Fel d I

Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23)

Immunotherapy in asthma: an updated systematic review.

Long-term clinical efficacy of grass-pollen immunotherapy.

Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses.

Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells.

Allergen-responsive CD4+CD25+ regulatory T cells in children who have outgrown cow's milk allergy.

Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper.

P2888

1710-1492-3-2-53

P304

53-59

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1710-1492-3-2-53

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2007-06-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44651122

http://www.w3.org/2001/XMLSchema#string

P6179

1003191228

http://www.w3.org/2001/XMLSchema#string

P698

20525144

http://www.w3.org/2001/XMLSchema#string

P921

immunotherapy

P932

2873623

http://www.w3.org/2001/XMLSchema#string

Immunotherapy with allergen peptides.

about

P2860

P2860

Immunotherapy with allergen peptides.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P6179

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P6179

P698

P921

P932